Oncolytics Biotech Receives German Clearance for Pancreatic Cancer Study
In This Article:
Oncolytics Biotech (ONC.TO), down 4.6% in U.S. pre-market trading, on Tuesday said it has obtained s
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.